Form D · Other Health Care
TPM Research, Inc.
Tuscaloosa, AL · CIK 0001933221
Offering snapshot reported Jun 10, 2022 · SEC filing
- Reported sold
- $1.78M Offering amount: $3.5M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- May 24, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2022 | Initial | $1,782,239 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448787
Source: Form D, filed Jun 10, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Comas | Director, Executive |
| Steven M. Dauphin | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1655 North Mcfarland Blvd. #192
Tuscaloosa, AL, 35406
Tuscaloosa, AL, 35406